Mural Oncology (MURA) Short Interest Ratio & Short Volume

Short interest is the volume of Mural Oncology shares that have been sold short but have not yet been covered or closed out. As of May 31st, investors have sold 341,900 shares of MURA short. 2.66% of Mural Oncology's shares are currently sold short. Learn More on Mural Oncology's current short interest.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Mural Oncology: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.66% of Mural Oncology's floating shares are currently sold short.

Mural Oncology saw a decrease in short interest in the month of May. As of May 31st, there was short interest totaling 341,900 shares, a decrease of 48.0% from the previous total of 657,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Mural Oncology currently has issued a total of 17,269,000 shares. Some of Mural Oncology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Mural Oncology currently has a public float of 12,830,000 shares.

2.66% of Mural Oncology's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Mural Oncology: Fate Therapeutics, Inc. (10.21%), INmune Bio, Inc. (43.02%), Eledon Pharmaceuticals, Inc. (2.77%), Puma Biotechnology, Inc. (7.44%), Janone Inc. (3.01%), Ventyx Biosciences, Inc. (10.69%), DiaMedica Therapeutics Inc. (2.77%), Neumora Therapeutics, Inc. (23.03%), enGene Holdings Inc. (0.18%), Larimar Therapeutics, Inc. (10.35%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks.

Short selling MURA is an investing strategy that aims to generate trading profit from Mural Oncology as its price is falling. MURA shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Mural Oncology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MURA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MURA, twice per month. The most recent reporting period available is May, 31 2025.